S. Muley

Determine Suitability of Isoxyl, A Mycolic Acid Inhibitor for Intermittent Chemotherapy of Tuberculosis

S. Vaidya, A. Chowdhary, M. Kulkarni, 2016 .

Restabilization treatment after intravenous immunoglobulin withdrawal in chronic inflammatory demyelinating polyneuropathy: Results from the pre‐randomization phase of the Polyneuropathy And Treatment with Hizentra study

D. Yarnitsky, M. Valis, H. Hartung, 2019, Journal of the peripheral nervous system : JPNS.

TO STUDY INCIDENCE OF MULTI DRUG RESISTANT TUBERCULOSIS IN MUMBAI

S. Vaidya, M. Kulkarni, G. Koppikar, 2015 .

To study intracellular bactericidal activity of Isoniazid & Rifampicin, alone and in combination with Isoxyl against standard and multi drug resistant strain of Mycobacterium tuberculosis in macrophage cell line

S. Vaidya, A. Chowdhary, M. Kulkarni, 2016 .

Efficacy and safety of IVIG in CIDP: Combined data of the PRIMA and PATH studies

G. L. Masson, D. Yarnitsky, M. Valis, 2019, Journal of the peripheral nervous system : JPNS.

DETERMINATION OF EFFICACY OF ISOXYL, A MYCOLIC ACID INHIBITOR, IN VITRO AGAINST MYCOBACTERIUM.TUBERCULOSIS STRAINS

S. Vaidya, A. Chowdhary, M. Kulkarni, 2015 .

To identify in vitro effective combination of Isoniazid and Rifampicinwith Isoxyl against Multi Drug Resistant and susceptible strains of Mycobacterium tuberculosis and Mycobacteria Other Than Tuberculosis strains by checkerboard titration

S. Vaidya, A. Chowdhary, M. Kulkarni, 2017 .